ABIVAX Société Anonyme (AAVXF)
OTCMKTS · Delayed Price · Currency is USD
71.02
+1.35 (1.94%)
Aug 6, 2025, 1:06 PM EDT
SolarWinds Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $5.39 billion as of August 6, 2025. Its market cap has increased by 599.31% in one year.
Market Cap
5.39B
Enterprise Value
5.39B
Revenue
11.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
$71.02
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 225.47M to 5.39B, an increase of 2,290.21%. That is a compound annual growth rate of 36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 5.25B | 1,083.94% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |